O	0	2	In	In	FW	B-NP
O	3	7	situ	situ	FW	I-NP
O	8	18	alkylation	alkylation	NN	I-NP
O	19	21	of	of	IN	B-PP
O	22	30	cysteine	cysteine	NN	B-NP
O	31	39	residues	residue	NNS	I-NP
O	40	42	in	in	IN	B-PP
O	43	44	a	a	DT	B-NP
O	45	56	hydrophobic	hydrophobic	JJ	I-NP
B-Cellular_component	57	65	membrane	membrane	NN	I-NP
O	66	73	protein	protein	NN	I-NP
O	74	85	immobilized	immobilize	VBN	B-VP
O	86	88	on	on	IN	B-PP
O	89	103	polyvinylidene	polyvinylidene	NN	B-NP
O	104	114	difluoride	difluoride	NN	I-NP
O	115	124	membranes	membrane	NNS	I-NP
O	125	127	by	by	IN	B-PP
O	128	143	electroblotting	electroblotte	VBG	B-VP
O	144	149	prior	prior	JJ	B-ADJP
O	150	152	to	to	TO	B-PP
O	153	166	microsequence	microsequence	NN	B-NP
O	167	170	and	and	CC	I-NP
O	171	176	amino	amino	NN	I-NP
O	177	181	acid	acid	NN	I-NP
O	182	190	analysis	analysis	NN	I-NP
O	190	191	.	.	.	O

O	192	195	For	For	IN	B-PP
O	196	210	identification	identification	NN	B-NP
O	211	213	of	of	IN	B-PP
O	214	222	cysteine	cysteine	NN	B-NP
O	223	231	residues	residue	NNS	I-NP
O	232	234	on	on	IN	B-PP
O	235	248	microsequence	microsequence	NN	B-NP
O	249	257	analysis	analysis	NN	I-NP
O	258	260	it	it	PRP	B-NP
O	261	263	is	be	VBZ	B-VP
O	264	271	crucial	crucial	JJ	B-ADJP
O	272	274	to	to	TO	B-VP
O	275	285	derivatize	derivatize	VB	I-VP
O	286	289	the	the	DT	B-NP
O	290	300	sulfhydryl	sulfhydryl	NN	I-NP
O	301	307	groups	group	NNS	I-NP
O	307	308	.	.	.	O

O	309	313	This	This	DT	B-NP
O	314	322	reaction	reaction	NN	I-NP
O	323	331	requires	require	VBZ	B-VP
O	332	333	a	a	DT	B-NP
O	334	343	desalting	desalt	VBG	I-NP
O	344	348	step	step	NN	I-NP
O	349	354	which	which	WDT	B-NP
O	355	360	often	often	RB	B-ADVP
O	361	371	represents	represent	VBZ	B-VP
O	372	373	a	a	DT	B-NP
O	374	379	major	major	JJ	I-NP
O	380	388	obstacle	obstacle	NN	I-NP
O	388	389	,	,	,	O
O	390	400	especially	especially	RB	B-ADVP
O	401	403	if	if	IN	B-SBAR
O	404	407	the	the	DT	B-NP
O	408	414	sample	sample	NN	I-NP
O	415	423	consists	consist	VBZ	B-VP
O	424	426	of	of	IN	B-PP
O	427	434	limited	limit	VBN	B-NP
O	435	442	amounts	amount	NNS	I-NP
O	443	445	of	of	IN	B-PP
O	446	447	a	a	DT	B-NP
O	448	459	hydrophobic	hydrophobic	JJ	I-NP
B-Cellular_component	460	468	membrane	membrane	NN	I-NP
O	469	476	protein	protein	NN	I-NP
O	476	477	.	.	.	O

O	478	480	An	An	DT	B-NP
O	481	491	alkylation	alkylation	NN	I-NP
O	492	501	procedure	procedure	NN	I-NP
O	502	504	is	be	VBZ	B-VP
O	505	514	described	describe	VBN	I-VP
O	514	515	,	,	,	O
O	516	524	allowing	allow	VBG	B-VP
O	525	534	efficient	efficient	JJ	B-NP
O	535	549	derivatization	derivatization	NN	I-NP
O	550	551	(	(	(	O
O	551	558	greater	great	JJR	B-ADJP
O	559	563	than	than	IN	B-PP
O	564	566	90	90	CD	B-NP
O	566	567	%	%	NN	I-NP
O	567	568	)	)	)	O
O	569	571	of	of	IN	B-PP
O	572	581	cysteines	cysteine	NNS	B-NP
O	582	585	and	and	CC	I-NP
O	586	594	cystines	cystine	NNS	I-NP
O	595	599	even	even	RB	B-ADVP
O	600	602	in	in	IN	B-PP
O	603	606	low	low	JJ	B-NP
O	607	616	microgram	microgram	NN	I-NP
O	617	627	quantities	quantity	NNS	I-NP
O	627	628	,	,	,	O
O	629	631	as	as	IN	B-SBAR
O	632	640	revealed	reveal	VBN	B-VP
O	641	643	by	by	IN	B-PP
O	644	648	test	test	NN	B-NP
O	649	657	analyses	analysis	NNS	I-NP
O	658	662	with	with	IN	B-PP
O	663	671	lysozyme	lysozyme	NN	B-NP
O	672	675	and	and	CC	O
O	676	677	a	a	DT	B-NP
O	678	689	hydrophobic	hydrophobic	JJ	I-NP
B-Cellular_component	690	698	membrane	membrane	NN	I-NP
O	699	706	protein	protein	NN	I-NP
O	706	707	.	.	.	O

O	708	711	The	The	DT	B-NP
O	712	720	modified	modify	VBN	I-NP
O	721	728	protein	protein	NN	I-NP
O	729	731	is	be	VBZ	B-VP
O	732	741	recovered	recover	VBN	I-VP
O	742	744	in	in	IN	B-PP
O	745	749	high	high	JJ	B-NP
O	750	756	yields	yield	NNS	I-NP
O	757	759	in	in	IN	B-PP
O	760	761	a	a	DT	B-NP
O	762	766	form	form	NN	I-NP
O	767	775	suitable	suitable	JJ	B-ADJP
O	776	779	for	for	IN	B-PP
O	780	784	both	both	CC	O
O	785	798	microsequence	microsequence	NN	B-NP
O	799	807	analysis	analysis	NN	I-NP
O	808	811	and	and	CC	O
O	812	817	amino	amino	NN	B-NP
O	818	822	acid	acid	NN	I-NP
O	823	831	analysis	analysis	NN	I-NP
O	831	832	.	.	.	O

O	833	836	The	The	DT	B-NP
O	837	843	method	method	NN	I-NP
O	844	852	involves	involve	VBZ	B-VP
O	853	868	electrophoretic	electrophoretic	JJ	B-NP
O	869	878	desalting	desalting	NN	I-NP
O	879	881	by	by	IN	B-PP
O	882	894	miniaturized	miniaturize	VBN	B-NP
O	895	902	Tricine	Tricine	NN	I-NP
O	902	903	-	-	HYPH	I-NP
O	903	909	sodium	sodium	NN	I-NP
O	910	917	dodecyl	dodecyl	NN	I-NP
O	918	925	sulfate	sulfate	NN	I-NP
O	925	926	-	-	HYPH	B-NP
O	926	940	polyacrylamide	polyacrylamide	NN	I-NP
O	941	944	gel	gel	NN	I-NP
O	945	960	electrophoresis	electrophoresis	NN	I-NP
O	961	964	and	and	CC	O
O	965	967	in	in	FW	B-NP
O	968	972	situ	situ	FW	I-NP
O	973	983	alkylation	alkylation	NN	I-NP
O	984	989	after	after	IN	B-PP
O	990	997	electro	electro	AFX	B-NP
O	997	998	-	-	HYPH	I-NP
O	998	1006	transfer	transfer	NN	I-NP
O	1007	1011	onto	onto	IN	B-PP
O	1012	1026	polyvinylidene	polyvinylidene	NN	B-NP
O	1027	1037	difluoride	difluoride	NN	I-NP
O	1038	1047	membranes	membrane	NNS	I-NP
O	1047	1048	.	.	.	O

O	1049	1060	Precautions	Precaution	NNS	B-NP
O	1061	1068	against	against	IN	B-PP
O	1069	1072	NH2	NH2	NN	B-NP
O	1072	1073	-	-	HYPH	B-NP
O	1073	1081	terminal	terminal	JJ	I-NP
O	1082	1090	blocking	blocking	NN	I-NP
O	1091	1097	during	during	IN	B-PP
O	1098	1104	sample	sample	NN	B-NP
O	1105	1117	preparations	preparation	NNS	I-NP
O	1118	1121	are	be	VBP	B-VP
O	1122	1130	provided	provide	VBN	I-VP
O	1130	1131	.	.	.	O

O	1132	1135	The	The	DT	B-NP
O	1136	1143	general	general	JJ	I-NP
O	1144	1157	applicability	applicability	NN	I-NP
O	1158	1160	of	of	IN	B-PP
O	1161	1164	the	the	DT	B-NP
O	1165	1171	method	method	NN	I-NP
O	1172	1174	is	be	VBZ	B-VP
O	1175	1186	illustrated	illustrate	VBN	I-VP
O	1187	1189	by	by	IN	B-PP
O	1190	1193	the	the	DT	B-NP
O	1194	1204	structural	structural	JJ	I-NP
O	1205	1221	characterization	characterization	NN	I-NP
O	1222	1224	of	of	IN	B-PP
O	1225	1228	the	the	DT	B-NP
O	1229	1232	low	low	JJ	I-NP
O	1233	1242	abundance	abundance	NN	I-NP
B-Cellular_component	1243	1251	membrane	membrane	NN	I-NP
O	1252	1260	receptor	receptor	NN	I-NP
O	1261	1264	for	for	IN	B-PP
O	1265	1270	human	human	JJ	B-NP
O	1271	1280	urokinase	urokinase	NN	I-NP
O	1281	1292	plasminogen	plasminogen	NN	I-NP
O	1293	1302	activator	activator	NN	I-NP
O	1302	1303	.	.	.	O

